细胞外膀衍生微RNA:癌症发病和治疗反应中的新兴游戏变革者
Faezeh Maroufi1,2, Amirali Ebrahimpour3, Fatemeh Davami2
1Department of Medical Biotechnology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Iranian biomedical journal
|February 21, 2026
概括
细胞外囊泡 (EVs) 携带影响癌症进展的微RNA (miRNAs). 这些EV衍生的miRNA显示出作为非侵入性生物标志物和癌症管理的治疗点的前景.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞生物学 细胞生物学
背景情况:
- 细胞间的通信对于多细胞生物来说至关重要,通过直接接触或分泌的分子进行中介.
- 细胞外囊泡 (EVs) 是关键的生物信使,在细胞之间运输生物活性分子.
- 瘤细胞与EV成分的相互作用会影响癌症的进展,包括扩散,转移,干细胞,化学抵抗和免疫调节.
研究的目的:
- 审查EV衍生的微RNAs (miRNAs) 在癌症中的功能作用.
- 突出EV衍生的miRNAs在癌症管理中的潜在临床应用.
主要方法:
- 对细胞外囊泡和癌症研究的文献综述.
- 分析非编码RNAs,特别是miRNAs在EVs中的作用.
- 检查诊断,预后和治疗的临床应用.
主要成果:
- EVs含有非编码RNAs (ncRNAs),特别是miRNAs,它们显著影响瘤微环境.
- EV衍生的miRNAs涉及各种与癌症相关的过程.
- 这些miRNA正在成为非侵入性癌症诊断和预后的有希望的工具.
结论:
- 来自EV的miRNAs在癌症的发展和进展中起着至关重要的功能作用.
- 来自EV的miRNAs代表了非侵入性癌症诊断和预后的潜在新生物标志物.
- 这些miRNAs也作为有效的癌症管理的治疗点具有前途.
更多相关视频
07:29Author Spotlight: Exploring the Mechanisms of MicroRNA Loading into Extracellular Vesicles in Cancer Progression
Published on: October 6, 2023
2.0K
12:18LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
6.2K
相关概念视频
MicroRNAs
4.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs
24.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Overview of Exosomes
3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
Mesenchymal Stem Cells
5.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
